Pharmaceutical

PTC Therapeutics gets grant for treatment of huntington’s disease using compound of formula (IBBL)

Discover the groundbreaking patent granted to PTC Therapeutics Inc for treating Huntington's disease with innovative compounds and pharmaceutical compositions. Explore the potential of Formula (I) and its various forms for effective treatment.

Mar 30, 2024 - 00:00
Discover the groundbreaking patent granted to PTC Therapeutics Inc for treating Huntington's disease with innovative compounds and pharmaceutical compositions. Explore the potential of Formula (I) and its various forms for effective treatment.
Read the original article

Tags:

Previous Article

Rohto Pharmaceutical gets grant for ophthalmic composition for treating myopia w...

Next Article

Gamida Cell gets grant for method of preparing transplantable NK cell fraction f...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AbbVie’s Q2 2024 net earnings drop to $1.37bn

AbbVie’s Q2 2024 net earnings drop to $1.37bn

Jul 28, 2024

STAT+: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries

STAT+: J&J agrees not to enforce patents on a key tuber...

Sep 30, 2023

STAT+: Consumer health advocate Sid Wolfe was a thorn in the side. We’re all the better as a result

STAT+: Consumer health advocate Sid Wolfe was a thorn i...

Jan 2, 2024